| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Francesco Giganti | Q59573911 |
| P2093 | author name string | Lei Tang | |
| Hideo Baba | |||
| Xue-Juan Wang | |||
| P2860 | cites work | Gastric cancer and imaging biomarkers: Part 1 - a critical review of DW-MRI and CE-MDCT findings | Q57045983 |
| A Collaborative Enterprise for Multi-Stakeholder Participation in the Advancement of Quantitative Imaging | Q57607579 | ||
| Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study | Q57807462 | ||
| Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations | Q72458494 | ||
| Role of ¹⁸F-FDG PET/CT in the prediction of gastric cancer recurrence after curative surgical resection | Q84311755 | ||
| The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancer | Q89285151 | ||
| Radiomic signature of 18F fluorodeoxyglucose PET/CT for prediction of gastric cancer survival and chemotherapeutic benefits | Q90910330 | ||
| Radiomics in esophageal and gastric cancer | Q90993767 | ||
| Global cancer statistics | Q22241238 | ||
| Value of the dynamic and delayed MR sequence with Gd-DTPA in the T-staging of stomach cancer: correlation with the histopathology | Q31475920 | ||
| Temporal resolution and SNR requirements for accurate DCE-MRI data analysis using the AATH model | Q33660443 | ||
| Pretreatment F-18 FDG PET/CT Parameters to Evaluate Progression-Free Survival in Gastric Cancer | Q33669818 | ||
| Detectability of T-Measurable Diseases in Advanced Gastric Cancer on FDG PET-CT. | Q33704647 | ||
| Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. | Q33744660 | ||
| Dynamic contrast-enhanced imaging techniques: CT and MRI | Q34203923 | ||
| Radiomics: Images Are More than Pictures, They Are Data | Q34502075 | ||
| Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. | Q34557123 | ||
| Clinical utility of quantitative imaging. | Q34656915 | ||
| Molecular basis of angiogenesis and cancer | Q35551132 | ||
| Prognostic value and clinical correlations of 18-fluorodeoxyglucose metabolism quantifiers in gastric cancer | Q35625394 | ||
| White paper on imaging biomarkers | Q35675618 | ||
| Angiogenesis in cancer | Q36746626 | ||
| Prognostic value of metabolic parameters on preoperative 18F-fluorodeoxyglucose positron emission tomography/ computed tomography in patients with stage III gastric cancer | Q37665536 | ||
| Role of imaging in predicting response to neoadjuvant chemotherapy in gastric cancer | Q38192620 | ||
| Dynamic contrast-enhanced MRI of gastric cancer: Correlation of the perfusion parameters with pathological prognostic factors | Q38232035 | ||
| Preoperative locoregional staging of gastric cancer: is there a place for magnetic resonance imaging? Prospective comparison with EUS and multidetector computed tomography | Q38329603 | ||
| The peak-standardized uptake value (P-SUV) by preoperative positron emission tomography-computed tomography (PET-CT) is a useful indicator of lymph node metastasis in gastric cancer | Q38473847 | ||
| Beyond gastric adenocarcinoma: Multimodality assessment of common and uncommon gastric neoplasms | Q38958977 | ||
| The Predictive and Prognostic Value of Early Metabolic Response Assessed by Positron Emission Tomography in Advanced Gastric Cancer Treated with Chemotherapy | Q41096858 | ||
| Modeling tracer kinetics in dynamic Gd-DTPA MR imaging | Q41352795 | ||
| [18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer | Q42963040 | ||
| FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings | Q44293162 | ||
| Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer | Q44761312 | ||
| Assessment of (18)F-fluorodeoxyglucose positron emission tomography combined with computed tomography in the preoperative management of patients with gastric cancer | Q44887860 | ||
| Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET. | Q44981568 | ||
| Perfusion and vascular permeability: basic concepts and measurement in DCE-CT and DCE-MRI. | Q45166287 | ||
| Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients with Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical Implication | Q47209139 | ||
| Feasibility of free-breathing dynamic contrast-enhanced MRI of gastric cancer using a golden-angle radial stack-of-stars VIBE sequence: comparison with the conventional contrast-enhanced breath-hold 3D VIBE sequence | Q47676027 | ||
| Prognostic significance of interim 18 F-fluorodeoxyglucose positron emission tomography-computed tomography volumetric parameters in metastatic or recurrent gastric cancer. | Q48143725 | ||
| Challenges and Promises of PET Radiomics. | Q50208342 | ||
| Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade | Q51142736 | ||
| Dynamic contrast-enhanced MRI of gastric cancer: Correlations of the pharmacokinetic parameters with histological type, Lauren classification, and angiogenesis | Q51329316 | ||
| Clinical implication of FDG-PET in advanced gastric cancer with signet ring cell histology. | Q53240780 | ||
| Predictive value of pretreatment metabolic activity measured by fluorodeoxyglucose positron emission tomography in patients with metastatic advanced gastric cancer: the maximal SUV of the stomach is a prognostic factor. | Q53379332 | ||
| Understanding the standardized uptake value, its methods, and implications for usage. | Q53612596 | ||
| 18FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study. | Q54970947 | ||
| Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study (PLASTIC-study). | Q54986076 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P433 | issue | 1 | |
| P921 | main subject | magnetic resonance imaging | Q161238 |
| stomach neoplasm | Q4335552 | ||
| Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography | Q130273251 | ||
| P304 | page(s) | 247-260 | |
| P577 | publication date | 2019-08-07 | |
| 2020-01-01 | |||
| P1433 | published in | European Radiology | Q5413071 |
| P1476 | title | Gastric cancer and image-derived quantitative parameters: Part 2-a critical review of DCE-MRI and 18F-FDG PET/CT findings | |
| P478 | volume | 30 |
Search more.